U.S. flag

An official website of the United States government

GRCh38/hg38 Xp22.2(chrX:12981073-13773690)x2 AND See cases

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Sep 27, 2013
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000140919.6

Allele description [Variation Report for GRCh38/hg38 Xp22.2(chrX:12981073-13773690)x2]

GRCh38/hg38 Xp22.2(chrX:12981073-13773690)x2

Genes:
  • LOC130067954:ATAC-STARR-seq lymphoblastoid active region 29426 [Gene]
  • LOC130067955:ATAC-STARR-seq lymphoblastoid active region 29427 [Gene]
  • LOC130067956:ATAC-STARR-seq lymphoblastoid active region 29428 [Gene]
  • LOC130067957:ATAC-STARR-seq lymphoblastoid active region 29429 [Gene]
  • LOC130067958:ATAC-STARR-seq lymphoblastoid active region 29430 [Gene]
  • LOC130067960:ATAC-STARR-seq lymphoblastoid active region 29431 [Gene]
  • LOC130067961:ATAC-STARR-seq lymphoblastoid active region 29432 [Gene]
  • LOC130067962:ATAC-STARR-seq lymphoblastoid active region 29433 [Gene]
  • LOC130067963:ATAC-STARR-seq lymphoblastoid active region 29434 [Gene]
  • LOC130067964:ATAC-STARR-seq lymphoblastoid active region 29435 [Gene]
  • LOC130067965:ATAC-STARR-seq lymphoblastoid active region 29436 [Gene]
  • LOC130067966:ATAC-STARR-seq lymphoblastoid active region 29437 [Gene]
  • LOC130067968:ATAC-STARR-seq lymphoblastoid active region 29438 [Gene]
  • LOC130067969:ATAC-STARR-seq lymphoblastoid active region 29439 [Gene]
  • LOC130067970:ATAC-STARR-seq lymphoblastoid active region 29440 [Gene]
  • LOC130067971:ATAC-STARR-seq lymphoblastoid active region 29442 [Gene]
  • LOC130067972:ATAC-STARR-seq lymphoblastoid active region 29444 [Gene]
  • LOC130067976:ATAC-STARR-seq lymphoblastoid active region 29445 [Gene]
  • LOC130067953:ATAC-STARR-seq lymphoblastoid silent region 20664 [Gene]
  • LOC130067959:ATAC-STARR-seq lymphoblastoid silent region 20665 [Gene]
  • LOC130067967:ATAC-STARR-seq lymphoblastoid silent region 20666 [Gene]
  • LOC130067973:ATAC-STARR-seq lymphoblastoid silent region 20667 [Gene]
  • LOC130067974:ATAC-STARR-seq lymphoblastoid silent region 20668 [Gene]
  • LOC130067975:ATAC-STARR-seq lymphoblastoid silent region 20669 [Gene]
  • LOC126863212:CDK7 strongly-dependent group 2 enhancer GRCh37_chrX:13752241-13753440 [Gene]
  • LOC116309144:CRISPRi-validated cis-regulatory element chrX.240 [Gene]
  • EGFL6:EGF like domain multiple 6 [Gene - OMIM - HGNC]
  • OFD1:OFD1 centriole and centriolar satellite protein [Gene - OMIM - HGNC]
  • LOC126863211:P300/CBP strongly-dependent group 1 enhancer GRCh37_chrX:13687079-13688278 [Gene]
  • RAB9A:RAB9A, member RAS oncogene family [Gene - OMIM - HGNC]
  • LOC125446272:Sharpr-MPRA regulatory region 14622 [Gene]
  • ATXN3L:ataxin 3 like [Gene - OMIM - HGNC]
  • FAM9C:family with sequence similarity 9 member C [Gene - OMIM - HGNC]
  • GPM6B:glycoprotein M6B [Gene - OMIM - HGNC]
  • LINC01203:long intergenic non-protein coding RNA 1203 [Gene - HGNC]
  • LINC02154:long intergenic non-protein coding RNA 2154 [Gene - HGNC]
  • MIR6086:microRNA 6086 [Gene - HGNC]
  • TRAPPC2:trafficking protein particle complex subunit 2 [Gene - OMIM - HGNC]
  • TCEANC:transcription elongation factor A N-terminal and central domain containing [Gene - OMIM - HGNC]
  • LOC105373133:uncharacterized LOC105373133 [Gene]
  • LOC107985657:uncharacterized LOC107985657 [Gene]
  • GS1-600G8.3:unknown transcript [Gene]
Variant type:
copy number gain
Cytogenetic location:
Xp22.2
Genomic location:
Preferred name:
GRCh38/hg38 Xp22.2(chrX:12981073-13773690)x2
HGVS:
  • NC_000023.11:g.(?_12981073)_(13773690_?)dup
  • NC_000023.10:g.(?_12999192)_(13791809_?)dup
Links:
dbVar: nssv1610475; dbVar: nsv932283
Observations:
1

Condition(s)

Name:
See cases [See the Variation display for details]
Identifiers:

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV000181764ISCA site 1

See additional submitters

no assertion criteria provided
Uncertain significance
(Sep 27, 2013) 		maternalclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedmaternalyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Miller DT, Adam MP, Aradhya S, Biesecker LG, Brothman AR, Carter NP, Church DM, Crolla JA, Eichler EE, Epstein CJ, Faucett WA, Feuk L, Friedman JM, Hamosh A, Jackson L, Kaminsky EB, Kok K, Krantz ID, Kuhn RM, Lee C, Ostell JM, Rosenberg C, et al.

Am J Hum Genet. 2010 May 14;86(5):749-64. doi: 10.1016/j.ajhg.2010.04.006. Review.

PubMed [citation]
PMID:
20466091
PMCID:
PMC2869000

Details of each submission

From ISCA site 1, SCV000181764.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1maternalyesnot providednot providedDiscovery1not providednot providednot provided

Last Updated: May 7, 2024